Coca-Cola Launches Data-Driven Insights Platform for Retail and Foodservice Industries 
McDonald's Faces Backlash Over $5 Meal Deal: Customers Call It 'Skimpy' 
Skepta and PUMA Launch Groundbreaking Collection 
Converse Faces Job Cuts as Nike Aims for $2 Billion in Cost Savings 
Skechers Sales Surge as Growth Lags for Nike and Adidas; Nike Eyes 2024 Olympics 
Why banks consider renewable energy to be a riskier investment than fossil fuels 
Aldi, Hy-Vee Recall Cream Cheese Products Over Potential Salmonella Contamination 
How supermarkets are changing their branding to make you think they’re cheaper 
Nike vs. Adidas: Anthony Edwards’ and Wembanyama’s Sneakers Soar in Popularity 
Shein's Potential London IPO Could Revitalize LSE Amid Geopolitical Tensions 
Coca-Cola Launches Lens Platform to Offer Key Data for Retail and Foodservice 
Semaglutide's Benefits Beyond Weight Loss: New Insights from the SELECT Trial 
McDonald's China Faces Backlash for Food Hygiene Violations 
Cancer drug pollution is a growing global concern 
 Market 2015-2019 - Advances in Technology / Availability of Alternate Technologies / Adoption of dPCR - EconoTimes)
Dublin, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/4dhxmc/global_digital) has announced the addition of the "Global Digital PCR (dPCR) Market 2015-2019" report to their offering.
The Global dPCR market to grow at a CAGR of 26.45 percent over the period 2014-2019.
The report, the Global dPCR Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region, and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Advanced dPCR (Digital PCR) technology provides higher accuracy and reproducibility than traditional PCR technology in the amplification and analysis of nucleic acids. The dPCR technology is an innovative PCR that allows amplification and directs quantification of nucleic acids such as DNA, RNA, cDNA, and methylated DNA with high precision. The dPCR technology is not dependent on the number of amplification cycles to quantify the initial sample amount and provides absolute quantification of nucleic acids. dPCR can analyze a small amount of sample and provide higher accuracy, precision, and efficiency than the conventional PCR technology.
According to the report, one of the major drivers of the market is advances in dPCR technology. dPCR technologies and products have improved because of automation, accuracy, sensitivity, and ease of handling. In addition, advanced dPCR products provide greater efficiency and productivity in research and drug discovery and help reduce the time taken for the development of new drugs.
Further, the report states that availability of alternative technologies is a major challenge that the market faces. Availability of other sequencing technologies such as other PCR techniques and NGS poses a serious threat to the adoption of dPCR technology.
The dPCR technologies have a broad range of applications in various fields including:
- Drug discovery and development
- Clinical diagnostics
- Research
- Others
Key Vendors
- Bio-Rad Laboratories
- Fluidigm
- RainDance Technologies
- Thermo Fisher Scientific
Other Prominent Vendors
- Abbott Laboratories
- Affymetrix
- Analytik Jena
- ArcticZymes
- Becton Dickinson
- Bibby Scientific
- bioMerieux
- Biosearch Technologies
- BIOTECON Diagnostics
- Eppendorf
- Exiqon
- Formulatrix
- Illumina
- Integrated DNA Technologies
- Promega
- Sigma-Aldrich
- Stilla Technologies
For more information visit http://www.researchandmarkets.com/research/4dhxmc/global_digital
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
